Publications by authors named "C Morelot-Panzini"

Dyspnea testifies to profound suffering in patients and its relief is a priority for caregivers. This can be achieved by correcting causative disorders ("etiopathogenic" approach) or targeting the dyspnea itself ("symptomatic" approach), as is done for pain. Empathetic solicitude from caregivers has an intrinsic analgesic effect, but its effects on dyspnea have not been formally documented.

View Article and Find Full Text PDF

Introduction And Objectives: Dyspnea is associated with fear and intense suffering and is often assessed using visual analog scales (VAS) or numerical rating scales (NRS). However, the physiological correlates of such ratings are not well known. Using the voluntary breath-holding model of induced dyspnea, we studied healthy volunteers to investigate the temporal relationship between dyspnea, the neural drive to breathe assessed in terms of involuntary thoracoabdominal movements (ITMs) and neurovegetative responses.

View Article and Find Full Text PDF

Background: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive diaphragm weakness and deteriorating lung function. Bulbar involvement and cough weakness contribute to respiratory morbidity and mortality. ALS-related respiratory failure significantly affects quality of life and is the leading cause of death.

View Article and Find Full Text PDF
Article Synopsis
  • The study explored how medical hypnosis can alleviate dyspnoea (difficulty breathing) compared to visual distraction techniques in healthy participants subjected to induced respiratory challenges.
  • 20 volunteers participated in controlled experiments to assess the effectiveness of hypnosis in reducing both sensory (physical sensation) and affective (emotional response) aspects of dyspnoea.
  • Results showed that medical hypnosis significantly outperformed visual distraction in reducing both dimensions of dyspnoea, suggesting its potential benefit for patients with persistent breathing difficulties.
View Article and Find Full Text PDF
Article Synopsis
  • The study examined whether Mas-receptor activation by BIO101 could help balance the Renin-Angiotensin System and reduce severe respiratory issues in hospitalized COVID-19 patients.
  • It was a double-blind, randomized trial involving 238 participants, with findings showing a 11.4% lower rate of respiratory failure or early death in the BIO101 group compared to placebo.
  • Results suggest BIO101 may reduce the risk of severe outcomes in COVID-19 patients, although further research is needed due to the low sample size.
View Article and Find Full Text PDF